Age‐Associated Senescence of Decidual Macrophages: A Key Mediator of Adverse Pregnancy Outcomes in Advanced Maternal Age
Aging Cell · 2026-07 · 25 (7)
DOI: 10.1111/acel.70614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 01.07.2026. Verfasst von Yujing Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Reproductive Health, Center for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Chi…. Hauptthemen laut MEDLINE: Macrophages, Decidua, Cellular Senescence, Pregnancy Outcome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key R&D Programs of Hubei Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Senescence of immune cells can drive senescence of solid organs, and reversing immune cell senescence ameliorates organismal senescence phenotypes. As the second largest subset of decidual immune cells, macrophages play a critical role in pregnancy. However, whether decidual macrophages (DM) exhibit senescence in advanced maternal age (AMA) pregnancies (≥ 35 years old) and their involvement in AMA‐related adverse outcomes remain undefined. This study elucidates the phenotypic and functional characteristics of DM in AMA pregnancies through clinical samples, animal models, and in vitro experiments. It clarifies the mechanisms underlying DM aging and explores novel intervention strategies to reverse DM aging and improve pregnancy outcomes in AMA pregnancies. We found that the presence of DM senescence in AMA pregnancies, manifested by an increased proportion of the pro‐inflammatory phenotype M1, increased expression of senescence markers (P53 and SA‐β‐Gal), and decreased phagocytic capacity—all associated with the development of adverse outcomes in AMA. The mechanistic basis of DM senescence involves two key pathways: on the one hand, low expression of forkhead box O3 causes DM senescence by downregulating mitophagy. On the other hand, elevated IL‐6 in the uterine microenvironment exacerbates senescence. Adoptive transfer of young mouse bone marrow‐derived macrophages significantly rescues embryo resorption rates and placental development in AMA pregnant mice. Overall, our study uncovers novel mechanisms and therapeutic strategies for AMA‐related adverse pregnancy outcomes through a new perspective of uterine macrophage senescence, providing new intervention ideas to improve adverse pregnancy outcomes in AMA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Reproductive Health, Center for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Laboratory of Animal Center, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Aihua Liao
Förderung
- National Natural Science Foundation of China
- Key R&D Programs of Hubei Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Zhang, Y., Zhang, Y., Gong, G., Li, Z., Xiong, W., Fang, X., Lu, N., Wang, D., Li, Y., & Liao, A. (2026). Age‐Associated Senescence of Decidual Macrophages: A Key Mediator of Adverse Pregnancy Outcomes in Advanced Maternal Age. Aging Cell, 25(7). https://doi.org/10.1111/acel.70614
Vancouver
Zhang Y, Zhang Y, Gong G, Li Z, Xiong W, Fang X, et al. Age‐Associated Senescence of Decidual Macrophages: A Key Mediator of Adverse Pregnancy Outcomes in Advanced Maternal Age. Aging Cell. 2026;25(7). doi:10.1111/acel.70614
BibTeX
@article{Zhang2026,
author = {Zhang, Yujing and Zhang, Yiming and Gong, Guangshun and Li, Zhijing and Xiong, Wenjing and Fang, Xuhui and Lu, Ning and Wang, Di and Li, Yihui and Liao, Aihua},
title = {Age‐Associated Senescence of Decidual Macrophages: A Key Mediator of Adverse Pregnancy Outcomes in Advanced Maternal Age},
journal = {Aging Cell},
year = {2026},
volume = {25},
number = {7},
doi = {10.1111/acel.70614}
}
EUVIMED